We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » India Limits Clinical Investigators to Three Trials Simultaneously
India Limits Clinical Investigators to Three Trials Simultaneously
August 26, 2014
Clinical trial investigators in India must limit their work to no more than three trials at any given time, according to one of the mandates in 14 finalized regulations issued by the Central Drugs Standard Control Organization.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor